Empagliflozin as treatment in glycogen storage disease type IB patients

Background: Glycogen Storage Disease Ib (GSD Ib) is a disease that associates both neutropenia and neutrophil dysfunction, thereby causing recurrent infections and inflammatory bowel disease (IBD). As of now, the standard treatment of these complications has been the administration of granulocyte-st...

Descripció completa

Dades bibliogràfiques

Autors principals:	María Arbelo Rodríguez, Elena Márquez Mesa, Cristina Lorenzo González, Marina Gutiérrez Vilar, Loredana Arhip, Mónica Ruiz Pons, José Pablo Suárez Llanos
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-06-01
Col·lecció:	Molecular Genetics and Metabolism Reports
Matèries:	Glycogen storage disease type Ib Empagliflozin Neutropenia Neutrophil dysfunction SGLT2 inhibitors 1,5-andhydroglucitol
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2214426925000412
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!